| Dietary protein restriction reprograms tumor-associated macrophages and enhances immunotherapy A Orillion, NP Damayanti, L Shen, R Adelaiye-Ogala, H Affronti, ... Clinical Cancer Research 24 (24), 6383-6395, 2018 | 87 | 2018 |
| EZH2 modifies sunitinib resistance in renal cell carcinoma by kinome reprogramming R Adelaiye-Ogala, J Budka, NP Damayanti, J Arrington, M Ferris, CC Hsu, ... Cancer research 77 (23), 6651-6666, 2017 | 77 | 2017 |
| Therapeutic targeting of TFE3/IRS-1/PI3K/mTOR axis in translocation renal cell carcinoma NP Damayanti, JA Budka, HWZ Khella, MW Ferris, SY Ku, E Kauffman, ... Clinical Cancer Research 24 (23), 5977-5989, 2018 | 74 | 2018 |
| Antitumor activity and mechanistic characterization of APE1/Ref-1 inhibitors in bladder cancer ML Fishel, H Xia, J McGeown, DW McIlwain, M Elbanna, AA Craft, ... Molecular cancer therapeutics 18 (11), 1947-1960, 2019 | 42 | 2019 |
| Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts L Wei, S Chintala, E Ciamporcero, S Ramakrishnan, M Elbanna, J Wang, ... Oncotarget 7 (47), 76374, 2016 | 36 | 2016 |
| Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases C Zhang, SR Stockwell, M Elbanna, R Ketteler, J Freeman, B Al-Lazikani, ... Oncogene 38 (30), 5905-5920, 2019 | 30 | 2019 |
| Clinical and preclinical outcomes of combining targeted therapy with radiotherapy M Elbanna, NN Chowdhury, R Rhome, ML Fishel Frontiers in Oncology 11, 749496, 2021 | 21 | 2021 |
| Baseline Karnofsky performance status is independently predictive of death within 30 days of intracranial radiation therapy completion for metastatic disease S McClelland III, N Agrawal, MF Elbanna, K Shiue, GK Bartlett, ... Reports of Practical Oncology & Radiotherapy 25 (4), 698-700, 2020 | 10 | 2020 |
| Dual inhibition of angiopoietin-TIE2 and MET alters the tumor microenvironment and prolongs survival in a metastatic model of renal cell carcinoma M Elbanna, AR Orillion, NP Damayanti, R Adelaiye-Ogala, L Shen, ... Molecular cancer therapeutics 19 (1), 147-156, 2020 | 10 | 2020 |
| Radiotherapy resources in Latin America and the Caribbean: a review of current and projected needs based on International Atomic Energy Agency data M Elbanna, Y Pynda, O Kalinchuk, A Rosa, M Abdel-Wahab The Lancet Oncology 24 (9), e376-e384, 2023 | 5 | 2023 |
| Alternative approaches to prevent androgen action in prostate cancer: are we there yet? M Elbanna, HV Heemers Discovery medicine 17 (95), 267-274, 2014 | 3 | 2014 |
| Social media for knowledge sharing and translation on justice, equity, diversity, and inclusion-Implementation and assessment of our first campaign I Pereira, S McVorran, GS Vidal, EC Fortune IV, K Taparra, KX Liu, ... Int J Radiat Oncol Biol Phys 111, e11, 2021 | 2 | 2021 |
| Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy M Elbanna, K Shiue, D Edwards, A Cerra-Franco, N Agrawal, J Hinton, ... Clinical lung cancer 22 (3), e342-e359, 2021 | 2 | 2021 |
| Methionine restriction increases macrophage tumoricidal activity and significantly inhibits prostate cancer growth AR Orillion, S Chintala, R Adelaiye-Ogala, L Shen, N Damayanti, ... Cancer Research 77 (13_Supplement), 250-250, 2017 | 2 | 2017 |
| Anti-tumor and anti-metastatic effect of sunitinib in a patient derived metastatic clear cell renal cell carcinoma xenograft model RM Adelaiye-Ogala, L Shen, S Chintala, E Ciamporcero, A Orillion, ... Cancer Research 75 (15_Supplement), 4132-4132, 2015 | 2 | 2015 |
| Inhibition of EZH2 overcomes resistance to sunitinib in clear cell renal cell carcinoma models RM Adelaiye-Ogala, S Chintala, L Shen, A Orillion, E Ciamporcero, ... Cancer Research 75 (15_Supplement), 3508-3508, 2015 | 2 | 2015 |
| Cultivating Cultural Humility to Address the Healthcare Burnout Epidemic–Why It Matters MF Elbanna, MR Thomas, PR Patel, MS McHenry Global Advances in Integrative Medicine and Health 12, 27536130231162350, 2023 | 1 | 2023 |
| In vitro modeling of patient derived bladder cancer cell lines in 3D culture systems M Elbanna, S Chintala, E Ciamporcero, R Adelayie, A Orillion, S Arisa, ... Cancer Research 77 (13_Supplement), 5783-5783, 2017 | 1 | 2017 |
| 37th International Symposium on Intensive Care and Emergency Medicine (part 1 of 3) Brussels, Belgium. 21–24 March 2017 V Karavana, I Smith, G Kanellis, I Sigala, T Kinsella, S Zakynthinos, L Liu, ... Critical Care 21, 1-66, 2017 | 1 | 2017 |
| Differential response to a dual PI3K/mTOR inhibitor in PIK3CA mutant urothelial cancer patient derived xenografts MF Elbanna, E Ciamporcero, R Adelaiye, A Orillion, S Chintala, R Pili Cancer Research 76 (14_Supplement), 384-384, 2016 | 1 | 2016 |
